Birgit Girshick
Chief Operating Officer bei CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Vermögen: 11 Mio $ am 31.03.2024
Profil
Birgit Girshick ist Mitglied des Verwaltungsrats von Charles River Discovery Research Services UK Ltd., Charles River Discovery Research Services Finland Oy, Argenta Discovery 2009 Ltd. und BioFocus DPI (Holdings) Ltd. sowie Chief Operating Officer bei Charles River Laboratories International, Inc. Frau Girshick erwarb einen MBA an der University of Rhode Island und einen Bachelor-Abschluss an der Eastern Connecticut State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
21.03.2024 | 40 907 ( 0,08% ) | 11 Mio $ | 31.03.2024 |
Aktive Positionen von Birgit Girshick
Unternehmen | Position | Beginn |
---|---|---|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Chief Operating Officer | 11.11.2021 |
Charles River Discovery Research Services Finland Oy
Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Director/Board Member | 01.10.2016 |
BioFocus DPI (Holdings) Ltd.
BioFocus DPI (Holdings) Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., BioFocus DPI (Holdings) Ltd. functions as an investment holding British company. The private company is based in Margate, UK. | Director/Board Member | - |
Argenta Discovery 2009 Ltd.
Argenta Discovery 2009 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Argenta Discovery 2009 Ltd. offers contract research drug discovery services. The private company is based in Margate, UK. | Director/Board Member | 28.09.2016 |
Charles River Discovery Research Services UK Ltd.
Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Director/Board Member | 28.09.2016 |
CRL Group France SAS
CRL Group France SAS Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., CRL Group France SAS is an investment holding French company. The private company is based in Miserey, France. The CEOs are Aidan John Synnott and John Curtin. The company was founded in 2002. | Chairman | 21.02.2020 |
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Director/Board Member | 11.01.2018 |
Ausbildung von Birgit Girshick
University of Rhode Island | Masters Business Admin |
Eastern Connecticut State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Commercial Services |
Private Unternehmen | 6 |
---|---|
Charles River Discovery Research Services UK Ltd.
Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Commercial Services |
Charles River Discovery Research Services Finland Oy
Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Commercial Services |
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Health Technology |
Argenta Discovery 2009 Ltd.
Argenta Discovery 2009 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Argenta Discovery 2009 Ltd. offers contract research drug discovery services. The private company is based in Margate, UK. | Commercial Services |
BioFocus DPI (Holdings) Ltd.
BioFocus DPI (Holdings) Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., BioFocus DPI (Holdings) Ltd. functions as an investment holding British company. The private company is based in Margate, UK. | Finance |
CRL Group France SAS
CRL Group France SAS Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., CRL Group France SAS is an investment holding French company. The private company is based in Miserey, France. The CEOs are Aidan John Synnott and John Curtin. The company was founded in 2002. | Finance |